Adipokines promote chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.4, 2013, Pages

  Rüster, Christiane ^a   Wolf, Gunter ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Adipokine; Endothelial dysfunction; Inflammation; Kidney disease; Oxidative stress

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSINOGEN; APELIN; C REACTIVE PROTEIN; CHEMERIN; ENDOTHELIN 1; ERYTHROPOIETIN STIMULATING AGENT; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGRANULIN; REACTIVE OXYGEN METABOLITE; RENIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADRENERGIC STIMULATION; ANEMIA; ATHEROSCLEROSIS; BODY MASS; BONE DENSITY; BONE TURNOVER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DYSLIPIDEMIA; END STAGE RENAL DISEASE; ENDOTHELIAL DYSFUNCTION; ERYTHROPOIESIS; FAT MASS; GENE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERLEPTINEMIA; HYPERLIPOPROTEINEMIA; HYPERTENSION; INNATE IMMUNITY; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; LIFESTYLE MODIFICATION; MACROALBUMINURIA; METABOLIC SYNDROME X; MICROALBUMINURIA; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OB GENE; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL; PROTEINURIA; RENAL ANEMIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; URINARY EXCRETION; WEIGHT REDUCTION;

ADIPOKINE; ENDOTHELIAL DYSFUNCTION; INFLAMMATION; KIDNEY DISEASE; OXIDATIVE STRESS;

ADIPOKINES; ANIMALS; HUMANS; METABOLIC SYNDROME X; RENAL INSUFFICIENCY, CHRONIC;

EID: 84890066129     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft191     Document Type: Review

References (49)

1. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
2. Tang J, Yan H, Zhuang S. Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol 2012; 2012: 608397
3. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301
4. Jia T, Carrero JJ, Lindholm B et al. The complex role of adiponectin in chronic kidney disease. Biochimie 2012; 94: 2150-2156
5. Inoue T, Sugiyama H, Kitagawa M et al. Suppression of adiponectinby aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo. PLoS One 2012; 7: e33965
6. Lenghel AR, Kacso IM, Bondor CI et al. Intercellular adhesionmolecule, plasma adiponectin and albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract 2012; 95: 55-61
7. Kacso IM, Bondor CI, Kacso G. Plasma adiponectin is related tothe progression of kidney disease in type 2 diabetes patients. Scand J Clin Lab Invest 2012; 72: 333-339
8. Engeli S, Feldpausch M, Gorzelniak K et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003; 52: 942-947
9. Nakamaki S, Satoh H, Kudoh A et al. Adiponectin reduces proteinuriain streptozotocin-induced diabetic Wistar rats. Exp Biol Med (Maywood) 2011; 236: 614-20
10. Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int 2009; 76: 145-148
11. Koshimura J, Fujita H, Narita T et al. Urinary adiponectinexcretion is increased in patients with overt diabetic nephropathy. Biochem Biophys Res Commun 2004; 316: 165-169
12. Knight SF, Quigley JE, Yuan J et al. Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension 2008; 51: 352-359
13. Beltowski J, Jamroz-Wisniewska A, Wojcicka G et al. Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension. Mol Cell Biochem 2008; 319: 163-174
14. Mak RH, Cheung W, Cone RD et al. Leptin and inflammation associated cachexia in chronic kidney disease. Kidney Int 2006; 69: 794-797
15. Sharma K, Considine RV, Michael B et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997; 51: 1980-1985
16. Wolf G, Ziyadeh FN. Leptin and renal fibrosis. Contrib Nephrol 2006; 151: 175-183
17. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001; 15: 2565-2571
18. Tanaka M, Suganami T, Sugita S et al. Role of central leptin signaling in renal macrophage infiltration. Endocr J 2010; 57: 61-72
19. Moschen AR, Kaser A, Enrich B et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178: 1748-1758
20. Song HK, Lee MH, Kim BK et al. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 2008; 295: F1485-F1494
21. Dimitriadis K, Tsioufis C, Selima M et al. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J Hum Hypertens 2009; 23: 668-673
22. Hu WL, Qian SB, Li JJ. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin. Cytokine 2007; 40: 201-206
23. Axelsson J, Bergsten A, Qureshi AR et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006; 69: 596-604
24. Bokarewa M, Nagaev I, Dahlberg L et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795
25. Therrien FJ, Agharazii M, Lebel M et al. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol 2012; 36: 51-61
26. Matoba K, Kawanami D, Ishizawa S et al. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells. Biochem Biophys Res Commun 2010; 402: 725-730
27. Pruijm M, Ponte B, Vollenweider P et al. Not all inflammatory markers are linked to kidney function: results from a populationbased study. Am J Nephrol 2012; 35: 288-294
28. Shankar A, Sun L, Klein BE et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 2011; 80: 1231-1238
29. Tomiyama-Hanayama M, Rakugi H, Kohara M et al. Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice. Am J Physiol Renal Physiol 2009; 297: F679-F684
30. Matsubara T, Mita A, Minami K et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab 2012; 15: 38-50
31. Richter J, Focke D, Ebert T et al. Serum levels of the adipokine progranulin depend on enal function. Diabetes Care 2013; 36: 410-414
32. Prior LJ, Eikelis N, Armitage JA et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010; 55: 862-868
33. Armitage JA, Burke SL, Prior LJ et al. Rapid onset of renal sympatheticnerve ctivation in rabbits fed a high-fat diet. Hypertension 2012; 60: 163-171
34. Tanida M, Shen J, Horii Y. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood) 2007; 232: 390-397
35. Kosari S, Rathner JA, Badoer E. Central resistin enhances renal sympathetic nerve activity via phosphatidylinositol 3-kinase but reduces the activity to brown adipose tissue via extracellular signal-regulated kinase 1/2. J Neuroendocrinol 2012; 24: 1432-1439
36. Thethi T, Kamiyama M, Kobori H. The link between the reninangiotensin- aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep 2012; 14: 160-169
37. Bacchetta J, Boutroy S, Guebre-Egziabher F et al. The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol Dial Transplant 2009; 24: 3120-3125
38. Okuno S, Ishimura E, Norimine K et al. Serum adiponectin and bone mineral density n male hemodialysis patients. Osteoporos Int 2012; 23: 2027-2035
39. Amemiya N, Otsubo S, Iwasa Y et al. Association between highmolecular- weight adiponectin and bone mineral density in hemodialysis patients. Clin Exp Nephrol 2012 (Epub ahead of print)
40. Matsunuma A, Horiuchi N. Leptin attenuates gene expression for renal 25- hydroxyvitamin D3-1alpha-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys 2007; 463: 1181-1127
41. Tsuji K, Maeda T, Kawane T et al. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J Bone Miner Res 2010; 25: 1711-1723
42. Axelsson J, Qureshi AR, Heimbürger O et al. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am J Kidney Dis 2005; 46: 628-634
43. Hung SC, Tung TY, Yang CS et al. High-calorie supplementation increases serum eptin levels and improves response to rHuEPO in long-term hemodialysis patients. Am J Kidney Dis 2005; 45: 1073-1083
44. Inrig JK, Bryskin SK, Patel UD et al. Association between high-dose erythropoiesis- stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors. BMC Nephrol 2011; 12: 67
45. Malyszko J, Malyszko JS, Pawlak K et al. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure. Adv Med Sci 2008; 53: 32-36
46. Day RT, Cavaglieri RC, Feliers D. Apelin retards the progression of diabetic nephropathy. Am J Physiol Renal Physiol 2013; 15: 304: F788-F800.
47. Pfau D, Bachmann A, Lössner U et al. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2010; 33: 171-173
48. Yamamoto T, Qureshi AR, Anderstam B et al. Clinical importance of an elevated circulating chemerin level in incident dialysis patients. Nephrol Dial Transplant 2010; 25: 4017-4023
49. Hu W, Feng P. Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract 2011; 91: 159-163